NoL and BIS Monitoring on Patients Recovery and Safety After Surgery

NAUnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

September 30, 2018

Study Completion Date

December 31, 2018

Conditions
PainAnesthesia
Interventions
DEVICE

BIS index/NoL index

"Remifentanil i.v. infusion will be run between 0.03 and 0.15 mcg/kg/min and boluses (0.4mcg/kg) will be given to keep a NoL index between 10-20.~Once intubated, the maintenance of anesthesia will be achieved with: desflurane set at 1 MAC to start, then adapted to the BIS between 45-55."

DEVICE

Variation of baseline mean arterial pressure

"Remifentanil i.v. infusion will be run between 0.03 and 0.15 mcg/kg/min and boluses (0.4mcg/kg) will be given to keep a baseline mean arterial pressure between 10% of variation.~Once intubated, the maintenance of anesthesia will be achieved with: desflurane set at 1 MAC to start, then ajusted to 0.8 MAC."

Trial Locations (1)

H1T2M4

RECRUITING

Hopital Maisonneuve Rosemont, CIUSSS de l'Est de l'Ile de Montreal, Montreal

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Canadian Anesthesiologists' Society

OTHER

collaborator

Medasense Biometrics Ltd

OTHER

lead

Maisonneuve-Rosemont Hospital

OTHER

NCT03410485 - NoL and BIS Monitoring on Patients Recovery and Safety After Surgery | Biotech Hunter | Biotech Hunter